Biblio Discovery — Demo Discovery Service

88 hasil untuk "Barbara Seliger"

Menampilkan 1–20 · 1,17 detik · RSS

  1. Artikel Jurnal

    Combination of multiple omics techniques for a personalized therapy or treatment selection

    Chiara Massa; Barbara Seliger

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Despite targeted therapies and immunotherapies have revolutionized the treatment of cancer patients, only a limited number of patients have long-term responses. Moreover, due to differences within cancer patients in the tumor mutational burden, composition of the tumor microenvironment as well as…

  2. Artikel Jurnal

    Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways

    Barbara Seliger; Chiara Massa

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Despite the broad application of different immunotherapeutic strategies for the treatment of solid as well as hematopoietic cancers, the efficacy of these therapies is still limited, with only a minority of patients having a long-term benefit resulting in an improved survival rate. In order to…

  3. Artikel Jurnal

    The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment—Review

    Barbara Seliger

    Frontiers in Immunology, Vol. 10 · 2019 · Inggris · DOAJ Scopus

    During the last decade, the dynamics of the cellular crosstalk have highlighted the significance of the host vs. tumor interaction. This resulted in the development of novel immunotherapeutic strategies in order to modulate/inhibit the mechanisms leading to escape of tumor cells from immune…

  4. Artikel Jurnal

    Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity

    Barbara Seliger

    Frontiers in Immunology, Vol. 10 · 2019 · Inggris · DOAJ Scopus

    Treatment of cancer patients has been recently revolutionized by the application of various immunotherapeutics. However, the response rates are still limited ranging between approximately 20 and 40% suggesting that combinations of immunotherapy with conventional treatment, like chemotherapy…

  5. Artikel Jurnal

    “Tumor Immunology Meets Oncology” (TIMO), 22 May–24 May 2025 in Brandenburg an der Havel, Germany

    Barbara Seliger

    Cancer Immunology, Immunotherapy, Vol. 75 No. 7 · 2026 · Inggris · DOAJ Scopus

    Abstract The “Tumor Immunology Meets Oncology” (TIMO XIX) meeting 2025 reports on the rapidly growing field of basic, but in particular translational tumor immunology thereby providing deeper insights into the heterogeneity of tumors, their microenvironment and clinical relevance. This represents…

  6. Artikel Jurnal

    “Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany

    Barbara Seliger

    Cancer Immunology, Immunotherapy, Vol. 74 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract The TIMO meeting XVIII 2024 covered both basic and translational tumor immunological topics, which were presented by national and international scientists and clinicians.

  7. Artikel Jurnal

    Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies

    Marcus Bauer; Chiara-Maria Schöbel; Claudia Wickenhauser dkk.

    Frontiers in Immunology, Vol. 15 · 2024 · Inggris · DOAJ Scopus

    Alternative splicing (AS) is an important molecular biological mechanism regulated by complex mechanisms involving a plethora of cis and trans-acting elements. Furthermore, AS is tissue specific and altered in various pathologies, including infectious, inflammatory, and neoplastic diseases…

  8. Artikel Jurnal

    Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies

    Barbara Seliger; Ulrike Koehl

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Natural killer (NK) cells belong to the family of innate immune cells with the capacity to recognize and kill tumor cells. Different phenotypes and functional properties of NK cells have been described in tumor patients, which could be shaped by the tumor microenvironment. The discovery of HLA…

  9. Artikel Jurnal

    PRELP-associated transcriptomic remodeling links alternative splicing and immune checkpoint blockade outcome in melanoma

    Karthikeyan Subbarayan; Kamatchi Ulagappan; Mario Udinotti dkk.

    Frontiers in Immunology, Vol. 17 · 2026 · Inggris · DOAJ Scopus

    BackgroundCutaneous melanoma is an aggressive malignancy characterized by a high metastatic potential and variable response to immune checkpoint blockade (ICB). The extracellular matrix protein proline/arginine-rich end leucine-rich repeat protein (PRELP), an extracellular matrix protein…

  10. Artikel Jurnal

    Role of HLA-G in Viral Infections

    Simon Jasinski-Bergner; Dominik Schmiedel; Ofer Mandelboim dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    The human leukocyte antigen (HLA)-G is a non-classical HLA class I molecule, which has distinct features to classical HLA-A, -B, -C antigens, such as a low polymorphism, different splice variants, highly restricted, tightly regulated expression and immune modulatory properties. HLA-G expression in…

  11. Artikel Jurnal

    Interferon lambda in anti-viral defense and cancer: dual roles, mechanism and therapeutic potential

    Juliane Blümke; Barbara Seliger

    Journal of Translational Medicine, Vol. 24 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background The type III interferon family, known as interferon lambda (IFN-λ), consists of four isoforms (IFN-λ1, IFN-λ2, IFN-λ3, and IFN-λ4) and plays essential roles in immune responses. It mediates anti-viral and anti-tumoral activities and is distinguished from type I and type II…

  12. Artikel Jurnal

    Identification of RNA-binding protein hnRNP C targeting the 3’UTR of the TAP-associated glycoprotein tapasin in melanoma

    Yuan Wang; Barbara Seliger

    OncoImmunology, Vol. 13 No. 1 · 2024 · Inggris · DOAJ Scopus

    Deregulation or loss of the human leukocyte antigen class I (HLA-I) molecules on tumor cells leading to inhibition of CD8+ T cell recognition is an important tumor immune escape strategy, which could be caused by a posttranscriptional control of molecules in the HLA-I pathway mediated by…

  13. Artikel Jurnal

    CyTOF as a suitable tool for stratification and monitoring of cancer patients

    Barbara Seliger; Chiara Massa

    Journal of Translational Medicine, Vol. 23 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Despite the recent implementation of immunotherapies into clinical practice of various tumor types, the immunobiology of tumors and in particular the role and clinical relevance of the different immune cell populations and their function still remained unclear. Therefore, an in depth…

  14. Artikel Jurnal

    The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition

    Abigael Eva Chaouat; Barbara Seliger; Ofer Mandelboim dkk.

    Frontiers in Immunology, Vol. 12 · 2021 · Inggris · DOAJ Scopus

    The coevolution of the human immune system and herpesviruses led to the emergence and diversification of both cellular danger molecules recognized by immune cells on the one hand and viral countermeasures that prevent the expression of these proteins on infected cells on the other. There are eight…

  15. Artikel Jurnal

    HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

    Barbara Seliger; Matthias Kloor; Soldano Ferrone

    OncoImmunology, Vol. 6 No. 2 · 2017 · Inggris · DOAJ Scopus

    The human leukocyte antigen (HLA) class II antigen-processing machinery (APM) presents to cognate CD4+ T-cells antigenic peptides mainly generated from exogeneous proteins in the endocytic compartment. These CD4+ T cells exert helper function, but may also act as effector cells, thereby recognizing…

  16. Artikel Jurnal

    Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy

    Barbara Seliger; Christoforos Vaxevanis; Michael Bachmann

    Journal for ImmunoTherapy of Cancer, Vol. 12 No. 8 · 2024 · Inggris · DOAJ Scopus

    The importance of the immune system in regulating tumor growth by inducing immune cell-mediated cytotoxicity associated with patients’ outcomes has been highlighted in the past years by an increasing life expectancy in patients with cancer on treatment with different immunotherapeutics. However…

  17. Artikel Jurnal

    Molecular mechanisms of human herpes viruses inferring with host immune surveillance

    Barbara Seliger; Simon Jasinski-Bergner; Ofer Mandelboim

    Journal for ImmunoTherapy of Cancer, Vol. 8 No. 2 · 2020 · Inggris · DOAJ Scopus

    Several human herpes viruses (HHVs) exert oncogenic potential leading to malignant transformation of infected cells and/or tissues. The molecular processes induced by viral-encoded molecules including microRNAs, peptides, and proteins contributing to immune evasion of the infected host cells are…

  18. Artikel Jurnal

    Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744

    Barbara Seliger; Michael Friedrich; Christoforos K Vaxevanis

    Journal for ImmunoTherapy of Cancer, Vol. 8 No. 1 · 2020 · Inggris · DOAJ Scopus

    Background To control gene expression, microRNAs (miRNAs) are of key importance and their deregulation is associated with the development and progression of various cancer types. In this context, a discordant messenger RNA/protein expression pointing to extensive post-transcriptional regulation of…